Sobre nosotros
Si tiene algún problema durante el uso del producto, no dude en ponerse en contacto con nosotros
Modern pharmaceutical glass manufacturing depends on more than production capacity. Pharmaceutical companies also need controlled processes, consistent container quality, traceable manufacturing data and reliable testing documentation.
LINUO Pharmaceutical Packaging has developed an intelligent manufacturing system that connects pharmaceutical glass production, automated inspection, digital process control, MES traceability and in-house laboratory testing.
Its manufacturing capabilities cover pharmaceutical borosilicate glass tubing, ampoules, tubular vials, glass cartridges, molded glass bottles and ready-to-use packaging. Each product category is supported by dedicated production equipment and inspection processes.
Con más de 30 años de experiencia, LINUO opera un complejo de fabricación inteligente de más de 900.000 m² con más de 500 máquinas de producción principales. Su capacidad anual publicada supera los 9.600 millones de unidades, respaldada por una producción interna anual de más de 13.000 toneladas de tubos de vidrio farmacéutico.

LINUO’s manufacturing chain begins with tubos de vidrio borosilicato farmacéutico and extends to finished pharmaceutical containers and RTU packaging.
The factory’s principal production categories include:
This manufacturing structure brings glass material production, container forming, surface processing, inspection, sterile preparation and supporting laboratory testing into one integrated system.
La capacidad interna de producción de tubos de vidrio suministra material para productos posteriores, como ampollas, viales tubulares y cartuchos. Esto crea una conexión trazable entre el material de vidrio y el envase farmacéutico terminado.

LINUO’s Phase III High-End Pharmaceutical Packaging Project is a major intelligent-manufacturing program centered on medium-borosilicate molded pharmaceutical glass bottles, advanced sterile packaging and digital factory operations.
The project represents a planned investment of RMB 2 billion and covers approximately 425 acres. It includes an innovation center with R&D facilities, an academician workstation, a specialty-glass materials research institute and supporting talent facilities.
The program combines lean manufacturing with 5G connectivity, artificial intelligence, big-data analytics and industrial automation. Its objective is to build a transparent, green and highly traceable pharmaceutical-packaging factory, with digital systems supporting production planning, process control, quality assurance, warehousing, energy management and customer response.
LINUO has been recognized as the first company in its industry to achieve Level 4 certification under the Intelligent Manufacturing Capability Maturity Model (CMMM). The company has also received recognition as a Shandong Intelligent Manufacturing Benchmark Enterprise, a provincial Advanced Smart Factory and a China Light Industry Digital Transformation Leading Practice.
LINUO’s smart factory combina supervisión digital, producción automatizada, inteligencia artificial y centralizada de datos.
El sistema de fabricación inteligente abarca varias áreas interconectadas:
El programa de la Fase III integra APS, MES, OMS, EMS, WMS, APC y aplicaciones digitales relacionadas en un único marco de gestión de la fabricación.
Un centro de comando de producción global está diseñado para supervisar los datos operativos de las plantas de fabricación nacionales e internacionales, con conectividad de video que cubre los principales puestos de producción.
LINUO utiliza una plataforma digital de gestión de la producción para supervisar la producción, los equipos y la información de los procesos.
El material de apoyo identifica a Siemens como parte de la plataforma de monitorización, mientras que las tecnologías de Horn y ANSYS se utilizan en aplicaciones de gemelos digitales. Estos sistemas ayudan a conectar la información de producción con la planificación de procesos y la gestión de equipos.
La fábrica también ha establecido un centro global de control de la producción. Este centro supervisa las operaciones de producción, la demanda de los clientes y los principales indicadores operativos en toda la red de fabricación de la empresa.

La inspección en línea está incorporada a las líneas de producción de distintos productos de vidrio farmacéutico.
Según la categoría del producto, LINUO utiliza sistemas de inspección CCD, inspección multicámara y sistemas de visión artificial con IA para identificar anomalías dimensionales o visuales durante la producción.
La información publicada sobre la fábrica incluye:
Within the verified application scope, the AI-supported quality system achieved defect-prediction accuracy above 90% and contributed to a 10% improvement in product yield.
Este enfoque amplía el monitoreo de la calidad al proceso de fabricación, en lugar de depender únicamente de la inspección del producto terminado.
LINUO utiliza un sistema de ejecución de fabricación para conectar la información sobre materiales, producción, inspección y embalaje.
Los registros trazables pueden incluir:
El sistema MES permite rastrear la información de calidad tanto hacia adelante como hacia atrás, desde la recepción de las materias primas hasta la producción y la entrega.
La fábrica inteligente también utiliza manipulación robótica y sistemas digitales de gestión energética.
LINUO aplica prácticas digitales de gestión de la energía y el carbono como parte de su estrategia de fabricación inteligente. El objetivo es reducir el consumo de energía y las emisiones, al tiempo que mejora la eficiencia de los hornos, los equipos y el movimiento de materiales.
Los sistemas robóticos KUKA se utilizan para el transporte de materiales, la paletización y el embalaje. Los sistemas digitales de gestión energética supervisan y gestionan el uso de energía en todas las instalaciones de fabricación.
Verified project data indicates that the applicable furnace system reduced energy consumption by 19%, equivalent to approximately 1.4 million kWh per furnace annually during the stated measurement period.
This approach supports the development of a green, low-carbon and circular manufacturing system, aligned with the company’s transparent-factory, green-factory and lighthouse-factory objectives.
La tecnología de gemelos digitales es una parte importante del sistema de fabricación inteligente de LINUO.
LINUO utiliza modelos virtuales de las líneas de producción para respaldar la simulación y el análisis de:
Este entorno digital permite revisar la información de producción y los datos de los equipos dentro de un modelo virtual de fabricación.
According to internally verified project data, the digital twin implementation improved production efficiency by 20%. More than 200,000 furnace operating data points were used for process modeling. These figures relate to the specified implementation scope and measurement period.
La tecnología de gemelos digitales también se aplica a los procesos de fusión y conformado del vidrio. La línea de botellas de vidrio moldeado utiliza un horno totalmente eléctrico con APC y soporte de gemelo digital, mientras que las plataformas digitales de producción permiten supervisar y analizar los procesos en otras áreas de la fábrica.
Within the specified glass-melting implementation scope, data-driven process control reduced the melt-related defect rate to 5% during the stated measurement period.

LINUO aplica controles automatizados en varias etapas de la producción de vidrio farmacéutico.
Los procesos de fabricación inteligente publicados por la fábrica incluyen:
Dosificación automática de materias primas
Transporte automatizado de materiales mediante RGV
Ajuste automático de los niveles de líquido del horno
Control de voltaje y corriente
Control de temperatura de circuito cerrado del horno de recocido
Inspección de calidad en línea
Embalaje automático
Almacenamiento inteligente
Within the verified automatic batching system, raw-material batching error was controlled below 0.1%.The integration of automation and production data allows key manufacturing parameters to be monitored throughout the production process.
El programa de fabricación inteligente extiende la automatización desde la preparación de materias primas hasta el almacenamiento de productos terminados.
Los sistemas de dosificación automática controlan la humedad de las materias primas y la fórmula, seguidos de la alimentación y el transporte automatizados. Las operaciones del horno cuentan con alimentación automática, control avanzado del proceso y monitoreo en tiempo real de las condiciones de fusión.
La red de fabricación incluye embalaje automatizado, paletizado, transporte de materiales mediante AGV y RGV, y almacenamiento inteligente. Estos sistemas están diseñados para reducir la manipulación manual, favorecer un flujo uniforme de materiales y conectar las operaciones de producción con la gestión del almacén.
The verified intelligent-logistics system includes an AGV and RGV network covering the applicable factory area and more than 50,000 automated-storage locations. Within the specified system, AGV replenishment response time is below three seconds, while the night-shift unattended-operation rate reaches 80%.
La inspección asistida por IA está integrada en las líneas de producción automatizadas para ampliar el control de calidad al proceso de fabricación. La inspección automatizada, los registros del MES y la verificación en laboratorio contribuyen conjuntamente a una estructura de gestión de la calidad de circuito cerrado, desde la recepción de materiales hasta la liberación del producto terminado.
LINUO opera líneas de producción especializadas para sus principales categorías de envases farmacéuticos. Cada línea combina equipos específicos para cada producto con las correspondientes capacidades de fabricación e inspección.

La línea de producción de ampollas integra conformado, recocido, inspección en línea y embalaje.
El equipo principal incluido para esta categoría de producción comprende:
Las capacidades publicadas de la línea incluyen:
LINUO manufactures clear and amber Type I borosilicate glass ampoules. Its product range includes ISO Forms B, C and D, together with OPC and CBR opening systems.

The tubular glass vial line focuses on high-precision forming, online quality inspection and protected packaging.
LINUO identifies the OCMI MF30 high-speed tubular container-forming machine as core equipment for this production line.
The line’s published capabilities include:
LINUO manufactures standard tubular glass vials in capacities from 1ml to 50ml. Micro-series 0.1ml and 0.3ml options are available upon request.The company also manufactures RTU glass vials in sizes from 2R to 50R.
LINUO’s glass cartridge production line uses SPMI equipment.
The line supports several manufacturing and finishing processes, including:
LINUO’s standard neutral borosilicate glass cartridges are available in 1.5ml, 1.8ml and 3ml formats.
Its RTU cartridge portfolio includes 1ml, 1.5ml, 1.8ml and 3ml standard cartridges, as well as 3ml, 4ml and 5ml dual-chamber cartridges.
The molded glass bottle production line combines automated forming, AI inspection and MES/WMS traceability.
The supporting factory material lists the following core equipment:
The published production capabilities include:
The 12-camera system provides 360-degree monitoring of molded pharmaceutical glass containers during production.
LINUO’s molded glass product portfolio includes standard, Tube-Look and lightweight series, with clear and amber glass options.
LINUO’s pharmaceutical glass tubing production line uses the Danner process.
Core equipment listed for the line includes:
The principal manufacturing capabilities include:
The pharmaceutical glass tubing produced on this line is used as the base material for downstream ampoule, vial and cartridge manufacturing.
LINUO reports annual pharmaceutical glass tubing output of more than 13,000 tons.

LINUO’s RTU production line supports ready-to-use glass vials and cartridges.
The supporting material identifies the following equipment and automation suppliers:
The RTU line operates in a Grade A, ISO 5 cleanroom environment.
Its published production capabilities include:
LINUO manufactures RTU glass vials in Nest and Tub and Tray formats. It also manufactures RTU sterile cartridges in Nest and Tub systems.
Depending on the selected product, the RTU packaging structure can include PP nests or trays, tubs, Tyvek sterile-barrier materials and double sterile bags.
LINUO’s Phase III development also includes a PFS and RTU smart factory for advanced sterile pharmaceutical packaging.
The planned facility is designed around a no-glass-to-glass-contact concept and combines internationally sourced production equipment, AI-supported quality assurance, flexible production scheduling, full-process data traceability, compliance support and closed-loop intelligent control.
Upon reaching planned capacity, the facility is expected to support annual production of approximately:
These capabilities are intended to expand LINUO’s offering of ready-to-use sterile packaging for injectable drug products, including RTU vials, RTU cartridges and prefillable syringe systems.
LINUO does not apply one identical inspection system to every pharmaceutical glass product. Its inspection configuration varies according to the container and manufacturing method.
The ampoule production line uses online inspection within the integrated forming, annealing and packaging process.
The tubular vial production line uses online quality inspection after precision forming. Non-contact packaging helps reduce surface contact after inspection.
The cartridge line includes dimensional and visual inspection before automatic packaging.
The molded glass bottle line uses a 12-camera AI system for 360-degree inspection.
The Danner glass tubing line uses multiple cameras to inspect the tubing during production.
The RTU line uses CCD and AI inspection in a Grade A, ISO 5 cleanroom environment.
This product-specific approach connects the inspection method with the manufacturing characteristics of each packaging category.
MES and WMS systems connect production and warehouse information across the factory.
The MES system records quality and manufacturing data, while WMS supports material and finished-product management.
Together, these systems provide traceability across:
On the molded bottle line, MES and WMS provide traceability from glass material through forming, inspection and finished-product storage.
On other lines, MES supports production and quality records from raw-material entry through finished-product delivery.
LINUO’s manufacturing system is supported by an in-house pharmaceutical packaging testing center.
The laboratory received CNAS accreditation in 2012 under accreditation number L5691. According to LINUO, the laboratory conducts testing to ChP, USP, EP and JP requirements.
Its published testing capabilities cover five principal areas.
The laboratory’s material and chemical analysis equipment includes:
These instruments support microscopy, elemental analysis and spectroscopy.
Published physical and mechanical testing capabilities include:
These tests support the evaluation of pharmaceutical glass material and container performance.
Dimensional and appearance measurement equipment includes:
These systems support dimensional control and visual quality evaluation.
Environmental and special testing capabilities include:
The laboratory uses autoclaves from MEMMERT, Tuttnauer, Systec and Huatai for sterilization-related validation.
Packaging and Logistics Validation
The supporting testing material also lists:
These automated systems support packaging and logistics-related evaluation.
Quality Control from Incoming Material to Product Release
LINUO’s quality-control system covers incoming materials, production processes and finished-product release.
The company reports 57 QA/QC inspection personnel working across its production lines.
Their responsibilities include:
Automated inspection monitors products during production. Laboratory testing supports material, chemical, physical, mechanical and dimensional evaluation. MES traceability connects the resulting quality data with the corresponding production batches.
This creates a connected quality-control structure covering:

LINUO reports more than 130 registered patents and participation in more than 20 national and industry standards.
The company also reports annual R&D investment exceeding US$4.2 million.
Its R&D and customization capabilities cover:
The published development process consists of four stages:
Consult → Prototype → Validate → Mass Produce
This connects customer requirements with product development, testing and commercial manufacturing.
LINUO’s website lists the following certifications and regulatory resources:
Its laboratory supports testing according to ChP, USP, EP and JP requirements.
The exact certifications and documents available for a specific product should be confirmed during project evaluation.
The value of LINUO’s smart pharmaceutical glass factory comes from connecting material production, container manufacturing, inspection, testing and documentation.
Its manufacturing structure provides:
Individual product specifications, surface treatments, packaging formats, certifications and testing requirements must still be confirmed for each project.

de LINUO smart pharmaceutical glass factory combines manufacturing scale with digital production control, specialized equipment, automated inspection and traceable quality data.
Its integrated production system covers pharmaceutical borosilicate glass tubing, ampoules, tubular vials, glass cartridges, molded pharmaceutical bottles and RTU packaging.
Siemens monitoring, Horn and ANSYS digital twin applications, MES and WMS traceability, KUKA robotic systems and product-specific AI inspection support the factory’s intelligent manufacturing structure.
The production system is further supported by a CNAS-accredited pharmaceutical packaging testing center with material, chemical, physical, mechanical and dimensional testing capabilities.
For pharmaceutical companies, CDMOs and packaging distributors, this integrated system provides one manufacturing platform for conventional pharmaceutical glass containers and ready-to-use packaging solutions.
What products are manufactured in LINUO’s pharmaceutical glass factory?
LINUO manufactures pharmaceutical borosilicate glass tubing, ampoules, tubular glass vials, neutral borosilicate glass cartridges, molded pharmaceutical glass bottles, RTU glass vials and RTU sterile glass cartridges. Its factory materials also present PFS production capabilities.
What digital systems are used in the smart factory?
The supporting materials identify Siemens monitoring, Horn and ANSYS digital twin applications, MES traceability, WMS warehouse management and digital energy-management systems.
How does LINUO inspect pharmaceutical glass products?
LINUO uses inspection systems configured for different products, including online ampoule and vial inspection, multi-camera glass tubing inspection, 12-camera molded bottle inspection and CCD/AI inspection on RTU lines.
Does LINUO produce its own pharmaceutical glass tubing?
Yes. LINUO reports annual pharmaceutical glass tubing output exceeding 13,000 tons. The tubing supports the production of ampoules, tubular vials and cartridges.
How does LINUO trace production quality?
LINUO uses MES to connect raw-material, production, inspection and packaging data. WMS also supports material and finished-product management.
Does LINUO have an in-house testing center?
Yes. LINUO operates a CNAS-accredited pharmaceutical packaging testing center under accreditation number L5691.
What pharmacopoeia requirements does the laboratory support?
LINUO states that its laboratory conducts testing according to ChP, USP, EP and JP requirements.
Can LINUO produce RTU pharmaceutical packaging?
Yes. LINUO manufactures RTU glass vials in Nest and Tub and Tray formats, together with RTU sterile glass cartridges in Nest and Tub systems.
Le responderemos en un plazo de 24 horas. Si se trata de un caso urgente, añada WhatsApp/WeChat: +8618615646416 o llame directamente al +8618615646416.
*Respetamos su confidencialidad y toda la información está protegida.
Solo utilizaremos su información para responder a su consulta y nunca enviaremos correos electrónicos no solicitados ni mensajes promocionales.